Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.730
-0.010 (-0.57%)
At close: Feb 13, 2026, 4:00 PM EST
1.749
+0.019 (1.12%)
After-hours: Feb 13, 2026, 7:24 PM EST
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $257.78 million as of February 13, 2026. Its market cap has increased by 6,417.13% in one year.
Market Cap
257.78M
Enterprise Value
252.76M
1-Year Change
6,417.13%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $257.78M, an increase of 243.39%. That is a compound annual growth rate of 29.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 257.78M | -26.38% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | 75.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 272.82M |
| Enlivex Therapeutics | 270.61M |
| Cellectis | 269.89M |
| Fennec Pharmaceuticals | 267.08M |
| Avalo Therapeutics | 265.66M |
| Climb Bio | 265.46M |
| Neurogene | 260.85M |
| Shattuck Labs | 258.81M |